Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Plug Power Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Plug Power Inc trades at $1.42 (market cap $2.18B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 4.1× Plug Power Inc's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Plug Power Inc for 42 Days on average.
| KYMR | PLUG | |
|---|---|---|
Market Cap | $8.87B | $2.18B |
Volume | 779,107 | 58,569,311 |
Sector | Health | Industrials |
52-Week High | $127.31 | $4.14 |
52-Week Low | $55.80 | $1.45 |
Typical Hold Time | 0 Days | 42 Days |
Enterprise Value | $8.26B | $3.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Plug Power (PLUG) trades at $1.45, down 10.49% today, reflecting ongoing operational challenges. The stock shows bearish technical signals with negative moving averages, while fundamentals reveal persistent losses with a -220.59% net income margin and negative cash flow. Recent news highlights strategic partnerships including a 280 MW electrolyzer agreement with Arcadia eFuels, but the company continues to miss earnings expectations consistently.
Despite analyst consensus favoring Buy ratings (44.73%), PLUG faces significant execution risks with negative profitability and high cash burn. The $3.33 price target suggests potential upside if green hydrogen adoption accelerates, but investors must weigh substantial operational losses against long-term growth prospects in the clean energy sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
